Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balances at beginning at Dec. 31, 2019 $ 152 $ 117,174 $ (112,740) $ 4,586
Balances at beginning (in shares) at Dec. 31, 2019 15,235,308      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation   228   228
Share-based compensation (in shares) 9,696      
Warrant exercises (cashless) $ 3 (3)    
Warrant exercises (cashless) (in shares) 262,145      
Net loss for the period     (2,055) (2,055)
Balances at ending at Mar. 31, 2020 $ 155 117,399 (114,795) 2,759
Balance at ending (in shares) at Mar. 31, 2020 15,507,149      
Balances at beginning at Dec. 31, 2020 $ 170 121,729 (119,522) 2,377
Balances at beginning (in shares) at Dec. 31, 2020 17,047,584      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Adoption of ASU 2020-06   (3,107)   (3,107)
Public offering of common stock $ 21 46,764   (46,785)
Public offering of common stock (in shares) 2,127,660      
Share-based compensation $ 1 319   320
Share-based compensation (in shares) 20,709      
Warrant and option exercises (cash and cashless) $ 15 130   145
Warrant and option exercises (cash and cashless) (in shares) 1,482,327      
Net loss for the period     (2,538) (2,538)
Balances at ending at Mar. 31, 2021 $ 207 $ 165,835 $ (122,060) $ 43,982
Balance at ending (in shares) at Mar. 31, 2021 20,678,280